|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02329 GLORY HEALTH
Nominal 
0.199 +0.003 (+1.531%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 324,178 | -67.170% | 2,705,332 | 2,506,285 | 3,904,672 | 9,898,401 |
| Cost of Sales | (319,809) | -42.396% | (2,149,768) | (2,556,565) | (3,791,155) | (8,651,166) |
| Gross Profit | 4,369 | -98.989% | 555,564 | (50,280) | 113,517 | 1,247,235 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (498,940) | 263,500 | 20,059 | 115,699 | |
| Change in FV & Impairment on Others | -- | -- | (59,642) | (59,264) | (88,075) | (112,233) | |
| Profit / (Loss) on Disposal | (8,373) | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (69,929) | (62,315) | 42,027 | 166,385 | |
| Profit / (Loss) before Taxation | (188,336) | 50.473% | (1,436,308) | (655,460) | (1,090,344) | 876,867 | |
| Taxation | 18,317 | -69.833% | 20,805 | 61,957 | 95,051 | (532,352) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (55,160) | -- | 175,074 | 29,532 | 82,511 | (116,182) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (225,179) | 283.878% | (1,240,429) | (563,971) | (912,782) | 228,333 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 38,958 | 1.145% | 996,117 | 488,055 | 651,128 | 287,934 |
| Depreciation & Amortisation | 23,502 | -40.872% | 89,651 | 95,281 | 123,027 | 225,239 |
| Directors' Emoluments | -- | -- | 6,978 | 6,316 | 8,783 | 11,644 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Disclaimer | Disclaimer | Unqualified (Modified Report) |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -5.070 | 284.091% | -28.000 | -13.000 | -21.000 | 5.140 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.153 | 0.115 | 0.136 | 0.978 |
| NBV per share ($) | 2.183 | -- | 2.234 | 2.513 | 2.640 | 2.859 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -225,179 |
| %Change | 283.878% |
| EPS / (LPS) | RMB -0.051 |
| NBV Per Share (¥) | RMB 2.183 |